Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05783297 · ClinicalTrials.gov registry record · NA

Midwest TXTXT Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence

A NA study of HIV Infections, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

Active
Registry status
NA
Development phase
600
Enrollment target
12
Study locations

NCT05783297 is a NA study of HIV Infections that is active but no longer recruiting, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 600 participants, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (35% higher). The trial reports 12 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05783297, a NA study of HIV Infections, is active but no longer recruiting, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
600 participants
Enrollment target
12
Study locations

Study Summary

This research study uses a cluster randomized controlled trial design to evaluate the effectiveness of Treatment Text (TXTXT) intervention on adherence and viral load suppression at 3- and 6- months post intervention initiation for youth and young adults with HIV. A total of 12 clinics will be randomized into one of the following two conditions: 1. Comparison Arm (n=6 clinics)- Clinics randomized to the comparison arm will have participants receive the standard of care for 3 months, followed by a 3-month intervention period. 2. Intervention Arm (n=6 clinics)- Clinics randomized to the intervention arm will have participants receive the TXTXT intervention for 6 months.

Conditions Studied

HIV Infections

Interventions

  • BEHAVIORAL Standard of Care
  • BEHAVIORAL Treatment Text (TXTXT)

Study Locations (12)

Illinois

  • University of Illinois at Chicago - Chicago
  • Howard Brown Health - Chicago

Indiana

  • Eskenazi Health - Indianapolis
  • Indiana University - Indianapolis

Texas

  • Baylor College of Medicine - Houston
  • Valley AIDS Council - McAllen

Florida

  • AIDS Healthcare Foundation - Fort Lauderdale

Louisiana

  • Comprehensive Care Center of Southwest Louisiana - Lake Charles

Michigan

  • Corktown Health Center - Detroit

Missouri

  • KC Care Health Center - Kansas City

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2023-04-17
Est. Completion 2025-08
Phase NA

Sponsor

Ann & Robert H Lurie Children's Hospital of Chicago

159 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05783297

The ClinicalTrials.gov registry entry for NCT05783297 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (35% higher). The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.

NCT05783297 reports 12 study locations spanning 9 distinct geographic areas - top geographies include Illinois, Indiana, Texas.

Frequently Asked Questions

What is clinical trial NCT05783297 about?

NCT05783297 is a clinical study titled "Midwest TXTXT Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence". This research study uses a cluster randomized controlled trial design to evaluate the effectiveness of Treatment Text (TXTXT) intervention on adherence and viral load suppression at 3- and 6- months post intervention initiation for youth and young adults with HIV. A total of 12 clinics will be rando...

What is the current status of trial NCT05783297?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2023-04-17. Estimated completion is 2025-08.

What conditions does trial NCT05783297 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT05783297?

The interventions under investigation include: Standard of Care (BEHAVIORAL), Treatment Text (TXTXT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05783297?

This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05783297 being conducted?

This trial has 12 study locations across Florida, Illinois, Indiana, Louisiana, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.